AU2003225971A1 - Substituted biaryl amides as c5a receptor modulators - Google Patents

Substituted biaryl amides as c5a receptor modulators

Info

Publication number
AU2003225971A1
AU2003225971A1 AU2003225971A AU2003225971A AU2003225971A1 AU 2003225971 A1 AU2003225971 A1 AU 2003225971A1 AU 2003225971 A AU2003225971 A AU 2003225971A AU 2003225971 A AU2003225971 A AU 2003225971A AU 2003225971 A1 AU2003225971 A1 AU 2003225971A1
Authority
AU
Australia
Prior art keywords
receptor modulators
substituted biaryl
biaryl amides
amides
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003225971A
Inventor
Yang Gao
Alan Hutchison
John Peterson
Wallace Pringle
Andrew Thurkauf
Taeyoung Yoon
He Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurogen Corp
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of AU2003225971A1 publication Critical patent/AU2003225971A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/62—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
AU2003225971A 2002-03-28 2003-03-25 Substituted biaryl amides as c5a receptor modulators Abandoned AU2003225971A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36846202P 2002-03-28 2002-03-28
US60/368,462 2002-03-28
US37215002P 2002-04-12 2002-04-12
US60/372,150 2002-12-04
PCT/US2003/009045 WO2003082826A1 (en) 2002-03-28 2003-03-25 Substituted biaryl amides as c5a receptor modulators

Publications (1)

Publication Number Publication Date
AU2003225971A1 true AU2003225971A1 (en) 2003-10-13

Family

ID=28678238

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003225971A Abandoned AU2003225971A1 (en) 2002-03-28 2003-03-25 Substituted biaryl amides as c5a receptor modulators

Country Status (4)

Country Link
EP (1) EP1487796A4 (en)
AU (1) AU2003225971A1 (en)
CA (1) CA2479928A1 (en)
WO (1) WO2003082826A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429666B2 (en) 2004-06-10 2008-09-30 Merck Frosst Canada Ltd. Pyridine analogs as C5a antagonists
RS50962B (en) * 2004-12-15 2010-10-31 Dompe Pha.R.Ma S.P.A. 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
EP1739078A1 (en) * 2005-05-30 2007-01-03 Jerini AG Antagonists of C5a-receptor
EP4015504A1 (en) 2008-12-22 2022-06-22 ChemoCentryx, Inc. C5ar antagonists
KR101628132B1 (en) * 2010-01-25 2016-06-08 주식회사 바이오씨에스 Novel biaryl amide derivatives, and composition comprising the same as an active ingredient
HUE033644T2 (en) 2010-06-24 2017-12-28 Chemocentryx Inc C5ar antagonists
RS56288B1 (en) 2011-10-18 2017-12-29 Astellas Pharma Inc Bicyclic heterocyclic compound
AR094929A1 (en) 2013-02-28 2015-09-09 Bristol Myers Squibb Co DERIVATIVES OF PHENYLPIRAZOL AS POWERFUL INHIBITORS OF ROCK1 AND ROCK2
WO2014134391A1 (en) 2013-02-28 2014-09-04 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
AU2015324111B2 (en) 2014-09-29 2021-04-01 Chemocentryx, Inc. Processes and intermediates in the preparation of C5aR antagonists
BR112018014222A2 (en) 2016-01-14 2018-12-11 Chemocentryx, Inc. c3 glomerulopathy treatment method
RU2748260C2 (en) 2016-04-04 2021-05-21 Кемосентрикс, Инк. SOLUBLE C5aR ANTAGONISTS
JP7141130B2 (en) 2017-05-31 2022-09-22 ケモセントリックス，インコーポレイティド 6-5 Fused Rings as C5a Inhibitors
MA48800A (en) 2017-05-31 2020-04-08 Chemocentryx Inc FUSED CYCLES 5-5 USED AS C5A INHIBITORS
AU2018359214A1 (en) 2017-10-30 2020-04-16 Chemocentryx, Inc. Deuterated compounds as immunomodulators
CN111788185A (en) 2017-12-22 2020-10-16 凯莫森特里克斯股份有限公司 Diaryl substituted 6,5 fused ring compounds as C5a inhibitors
KR20200110656A (en) 2017-12-22 2020-09-24 케모센트릭스, 인크. Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
CA3095184A1 (en) 2018-04-02 2019-10-10 Chemocentryx, Inc. Prodrugs of fused-bicyclic c5ar antagonists

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965646A (en) * 1960-12-20 Pyrtoylmethyldibenzylamines
US2149279A (en) * 1934-07-07 1939-03-07 Merck & Co Inc Derivatives of pyrazine carboxylic acid and processes for their production
CH293880A (en) * 1951-01-30 1953-10-15 Ciba Geigy Process for the production of an azo pigment.
GB919073A (en) * 1960-09-15 1963-02-20 Farmaceutici Italia Benzylamine derivatives
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides
JPS61165339A (en) * 1985-01-16 1986-07-26 Tokuyama Soda Co Ltd Production of amide compound
KR100188801B1 (en) * 1990-05-18 1999-06-01 엥겔하르트 라피체 Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, drugs contaning these compounds and use of such drugs
CA2230894A1 (en) * 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
JP4327249B2 (en) * 1995-12-29 2009-09-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド Phenylthiazole derivatives with anti-herpesvirus properties
AU3880097A (en) * 1996-08-14 1998-03-06 Warner-Lambert Company Low molecular weight dendritic compounds as pharmaceutical agents
EP0946587A2 (en) * 1996-12-16 1999-10-06 Fujisawa Pharmaceutical Co., Ltd. New amide compounds
AU3665199A (en) * 1998-04-29 1999-11-16 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
EP1322309B1 (en) * 2000-09-29 2008-08-13 Neurogen Corporation High affinity small molecule c5a receptor modulators
GB0126292D0 (en) * 2001-11-01 2002-01-02 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
WO2003082826A1 (en) 2003-10-09
EP1487796A4 (en) 2005-11-16
CA2479928A1 (en) 2003-10-09
EP1487796A1 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
AU2003245773A1 (en) Vanilloid receptor modulators
EP1490043A4 (en) Spirocyclic amides as cannabinoid receptor modulators
AU2003225971A1 (en) Substituted biaryl amides as c5a receptor modulators
AU2003290778A1 (en) Non-steroidal farnesoid x receptor modulators
GB2384570B (en) Modulators
AU2003281040A1 (en) Biaryl derivatives
AU2003259482A1 (en) N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
AU2003209388A1 (en) Substituted imidazoles as cannabinoid receptor modulators
EP1569685B8 (en) Complement receptor 2 targeted complement modulators
EP1581217A4 (en) Carbonylamino-benzimidazole derivatives as androgen receptor modulators
PL373656A1 (en) Substituted amides
HRP20130638T1 (en) Cannabinoid receptor modulator
AU2003254177A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
EP1575901A4 (en) Substituted amides
AU2003251853A1 (en) Network attached encryption
AU2003256923A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
EP1682494A4 (en) Aralkyl amines as cannabinoid receptor modulators
AU2003218374A1 (en) Substituted tetrahydroisoquinolines as c5a receptor modulators
AU2003237492A1 (en) Urotensin ii receptor modulators
AU2003265625A1 (en) Amino methyl imidazoles as c5a receptor modulators
AU2003249722A1 (en) Therapeutic amides
IL166069A0 (en) CCK-1 receptor modulators
AU2002335075A1 (en) Estrogen receptor modulators
AU2003231523A1 (en) Estrogen receptor modulators
AU2003236243A1 (en) Novel nateglinide crystal

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase